- Investing Ideas
- /
- Singaporean Pharmaceuticals & Biotech Potentially Undervalued Companies
Singaporean Pharmaceuticals & Biotech Potentially Undervalued Companies
Results
3
Companies with a Value score of at least 3, ordered by Value score
3 companies
China Medical System Holdings
Market Cap: S$34.9b
An investment holding company, manufactures, sells, markets, and promotes pharmaceutical products in the People’s Republic of China.
8A8
S$2.48
7D
-0.8%
1Y
n/a
Pharmesis International
Market Cap: S$14.4m
An investment holding company, research, develops, produces, packages, sells, and markets western medicines and traditional Chinese medicine (TCM) formulated products for hospitals and medical institutions in the People’s Republic of China.
BFK
S$0.46
7D
0%
1Y
261.1%
Hyphens Pharma International
Market Cap: S$115.8m
Operates as a specialty pharmaceutical and consumer healthcare company primarily in Singapore, Vietnam, Malaysia, and internationally.
1J5
S$0.38
7D
1.4%
1Y
29.3%